|
|
|||||||||
|
|
|||||||||
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Investigation |
1 Neurosurgical Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands; and 2 Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, The Netherlands
Correspondence: For correspondence or reprints contact: Hedy Folkersma, Neurosurgical Center Amsterdam, VU University Medical Center, De Boelelaan 1117, NL-1081 HV, Amsterdam, The Netherlands. E-mail: hedy.folkersma{at}vumc.nl
(R)-[11C]PK11195 is a tracer for activated microglia. The purpose of this study was to assess the validity of the simplified reference tissue model for analyzing (R)-[11C]PK11195 studies in traumatic brain injury (TBI), where blood–brain barrier disruptions are likely. Methods: Dynamic (R)-[11C]PK11195 scans were acquired at 3 time points after TBI. Plasma input–derived binding potential (BPNDPI), volume of distribution (VT) and K1/k2, and simplified reference tissue model–derived binding potential (BPNDSRTM) were obtained. Simulations were performed to assess the effect of varying K1/k2. Results: Early after TBI, an increase in VT, but not in BPNDPI, was found. Early K1/k2 correlated with VT and BPNDSRTM but not with BPNDPI. One and 6 mo after TBI, BPNDSRTM correlated with BPNDPI. Conclusion: Early after TBI, (R)-[11C]PK11195 studies should be analyzed using plasma input models.
Key Words: blood–brain barrier craniocerebral trauma (R)-[11C]PK11195 humans positron emission tomography
COPYRIGHT © 2009 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |